FDA Takes Aim at Bioidentical Hormones
In a significant victory for physicians and patients, the U.S. Food and Drug Administration (FDA) announced on January 9 that it has begun enforcement action against seven compounding pharmacies making false and misleading claims about the safety and efficacy of "bioidentical hormones."
|
Endocrine Society Featured in On-line Video
The video, which is based on the ENDO 07 roundtable “Redefining Aging: the Impact of Endocrine Research,” is one of the primary outcomes of the Society’s year-long collaboration with Discover Magazine to explore the potential opportunities and risks surrounding the use of hormones in an attempt to forestall the effects of aging.
|
Temporary Physician Pay Fix Sets Stage for Uphill Battle in 2008
As 2007 was coming to a close, Congress passed S. 2499, the Medicare, Medicaid, and S-CHIP Extension Act of 2007, temporarily halting the 10.1 percent Medicare physician payment cut that was set to begin on January 1, 2008.
|
NIH to See Small Increase in FY 2008; Bill Includes New Language on Open Access
After a drawn-out process including several continuing resolutions and a failed veto override attempt, Congress and the president have agreed upon appropriations for FY 2008 in an omnibus spending package that was signed into law on December 26, 2007.
|
Three Clinical Practice Guidelines Approved
During its recent January meeting, The Endocrine Society’s Council approved three clinical practice guidelines—Diagnosis of Cushing’s Syndrome, Primary Prevention of Cardiovascular Disease and Type 2 Diabetes in Patients at Metabolic Risk, and Case Detection, Diagnosis, and Treatment of Patients with Primary Aldosteronism.
|
New NIH Policy Eases Burden of Peer Review
Applications submitted under this policy will be reviewed no later than 120 days after date of submission.
|
